<p>Bharat Biotech Co-Founder and Joint MD Suchitra Ella on Tuesday said that Covaxin has reached 30 cities in 30 days despite some employees being off work due to Covid-19.</p>.<p>"Covaxin reaches 30 cities within 30 day. All our employees are committed, working 24x7 thru lockdowns for the country's immunisation - pls send your prayers to their families, some are still quarantined & off work," Ella said in a tweet.</p>.<p><strong>Also Read | <a href="https://www.deccanherald.com/business/bharat-biotechs-us-partner-ocugen-submits-master-file-to-fda-on-covaxin-989729.html" target="_blank">Bharat Biotech's US partner Ocugen submits 'Master File' to FDA on Covaxin</a></strong></p>.<p>By way of dispatch to private hospitals, the vaccine has reached various cities, including Amritsar, Bangalore, Chennai, Delhi, Ernakulam, Jaipur, Hyderabad, Kanpur, Kolkata, Guwahati, Mysore, Pune, Raipur, Mohali and Vijayawada.</p>.<p>Last week, Bharat Biotech said it plans to produce an additional 200 million (20 crore) doses of Covaxin at its subsidiary's facility in Gujarat. This will take the overall production volume of the vaccine to about 1 billion (100 crore) doses per annum.</p>
<p>Bharat Biotech Co-Founder and Joint MD Suchitra Ella on Tuesday said that Covaxin has reached 30 cities in 30 days despite some employees being off work due to Covid-19.</p>.<p>"Covaxin reaches 30 cities within 30 day. All our employees are committed, working 24x7 thru lockdowns for the country's immunisation - pls send your prayers to their families, some are still quarantined & off work," Ella said in a tweet.</p>.<p><strong>Also Read | <a href="https://www.deccanherald.com/business/bharat-biotechs-us-partner-ocugen-submits-master-file-to-fda-on-covaxin-989729.html" target="_blank">Bharat Biotech's US partner Ocugen submits 'Master File' to FDA on Covaxin</a></strong></p>.<p>By way of dispatch to private hospitals, the vaccine has reached various cities, including Amritsar, Bangalore, Chennai, Delhi, Ernakulam, Jaipur, Hyderabad, Kanpur, Kolkata, Guwahati, Mysore, Pune, Raipur, Mohali and Vijayawada.</p>.<p>Last week, Bharat Biotech said it plans to produce an additional 200 million (20 crore) doses of Covaxin at its subsidiary's facility in Gujarat. This will take the overall production volume of the vaccine to about 1 billion (100 crore) doses per annum.</p>